Results 71 to 80 of about 8,401,904 (201)

Q1311X: a novel nonsense mutation of putative ancient origin in the von Willebrand factor gene [PDF]

, 2000
[EN] Type 3 von Willebrand disease, a recessive autosomally inherited bleeding disorder, refers to complete deficiency of von Willebrand factor (VWF).
Haya, Saturnino, Aznar, José A., Casaña, Pilar, Martínez, Francisco, Espinós-Armero, Carmen Ángeles, Lorenzo, José Ignacio   +5 more
core   +1 more source

Acquired von Willebrand syndrome in a patient with rectal adenocarcinoma: a case report and review of the literature

Journal of Medical Case Reports
Background Acquired von Willebrand syndrome is a rare and often underdiagnosed entity, secondary to different pathologies, often of autoimmune or paraneoplastic etiology.
Stefano De Polo, Mariangela Costanza, Francesco Grandoni, Lorenzo Alberio, Gerasimos Tsilimidos   +4 more
doaj   +1 more source

Von Willebrand factor antigen levels.

, 2017
Von Willebrand factor antigen levels.
Thomas Schmitz-Rode (838878), Ulrich Steinseifer (3778330), Ajay Moza (716042), Ruediger Autschbach (3729067), Rashad Zayat (3729064), Eva Woelke (3778333), Andreas Goetzenich (515289), Lachmandath Tewarie (3729058), Judith Maas (3778342), Christina Feldmann (3778339), Ali Aljalloud (3778336)   +10 more
core   +1 more source

Von Willebrand factor activity levels.

, 2017
Von Willebrand factor activity levels.
Thomas Schmitz-Rode (838878), Ulrich Steinseifer (3778330), Ajay Moza (716042), Ruediger Autschbach (3729067), Rashad Zayat (3729064), Eva Woelke (3778333), Andreas Goetzenich (515289), Lachmandath Tewarie (3729058), Judith Maas (3778342), Christina Feldmann (3778339), Ali Aljalloud (3778336)   +10 more
core   +1 more source

Individualizing dosing frequency may improve the efficacy of prophylaxis in patients with von Willebrand disease—a WIL-31 subanalysis

Research and Practice in Thrombosis and Haemostasis
Background: The efficacy and safety of prophylaxis with wilate, a plasma-derived von Willebrand factor/factor VIII concentrate, was demonstrated in patients with von Willebrand disease of all types in the WIL-31 study.
Robert F. Sidonio, Jr., Ana Boban, Toshko Lissitchkov, Laszlo Nemes, Vladimir Vdovin, Claudia Djambas Khayat   +5 more
doaj   +1 more source

Validation of a Von Willebrand factor propeptide assay

, 2018
Von Willebrand disease is the most common inherited bleeding disorder caused by a deficiency or defect in von Willebrand factor. Quantitative defects of von Willebrand factor include, type 1 von Willebrand disease (partial deficiency of von Willebrand ...
Maleka, Rethabile Brigette
core   +2 more sources

A Comparison of Endothelial Cell-Selective Adhesion Molecule and von Willebrand Factor Expression in Breast Cancer Growth and Metastasis

Middle East Journal of Cancer, 2018
Background: Angiogenesis is the process of new blood vessels formation that contribute to tumor growth and metastasis. Endothelial cell-selective adhesion molecule is one of the proteins that expresses in vascular endothelial cells.
M Husni Cangara, Mochammad Hatta, Upik A Miskad, Syarifuddin Wahid   +3 more
doaj  

Determinación del factor von Willebrand para la confirmación de la enfermedad de von Willebrand en Nicaragua

, 2020
Von Willebrand's disease is the most frequent hemorrhagic diathesis worldwide affecting men and women. Currently, there are 3 types of von Willebrand ´s disease: type 1, 2A, 2B, 2M, 2N, and 3, with type 1 being the most frequent.
Bonilla, Orlando, Espinoza, Aryeris, Berrios, René, Gutiérrez, Dania, Pernudy, Allan   +4 more
core  

A Rare Case of Klippel Trenaunay Syndrome with Von Willebrand Factor Deficiency and Multiple Accessory Spleens: A Case Report and Brief Literature Review

Advanced Biomedical Research
Klippel Trenaunay Syndrome (KTS) is an uncommon inherited syndrome identified by venous varicosities and capillary abnormalities. von Willebrand Disease is the most common inherited hemorrhage disturbance in humans, leading to insufficiency in von ...
Vahid Falahati, Mahsa Fallahi, Mona Shahriarpour, Ali Ghasemi, Kazem Ghaffari   +4 more
doaj   +1 more source

Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations: is it of clinical importance?

Haematologica, 2003
Factor VIII inhibitors may interfere with several important functional binding sites on the factor VIII molecule including that of von Willebrand factor, which binds to the C2 domain.
E Berntorp
doaj